AKASA

About AKASA

AKASA provides generative AI solutions for the healthcare revenue cycle, helping health systems reduce denials, improve margins, and increase revenue.

AKASA is the leading provider of generative AI solutions for the healthcare revenue cycle. The company leverages deep RCM expertise and GenAI trained on clinical and financial data to power its platform and solutions. AKASA's customer base represents 650+ hospitals and 6,500+ outpatient facilities across all 50 states, with total client net patient revenue over $120B. The company's product suite includes Prebill Optimization Suite, Coding Optimizer, CDI Optimizer, AI Advisor, Auth Status, and Claim Status, all aimed at streamlining revenue cycle operations. AKASA has raised over $205M in funding from investors including Andreessen Horowitz, BOND, and Costanoa Ventures.